MedTrace Logo

Evaluation of the MP Diagnostics HTLV Blot 2.4

NCT01467024 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2011-11-08

No results posted yet for this study

Summary

The purpose of this study is:

1. To assess the validity and reproducibility of the MP Diagnostics HTLV Blot 2.4.
2. To conduct a sensitivity analysis of the HTLV Blot 2.4 using a known positive population.

Conditions

  • HTLV-I Infections
  • HTLV-II Infections
  • Human T-lymphotropic Virus 1
  • Human T-lymphotropic Virus 2
  • HTLV I Associated T Cell Leukemia Lymphoma
  • HTLV I Associated Myelopathies

Interventions

OTHER

CDPHL Algorithm

Supplemental testing algorithm performed by the CDPHL.

Sponsors & Collaborators

  • Vital Systems Inc.

    collaborator OTHER

  • MP Biomedicals, LLC

    lead INDUSTRY

Principal Investigators

  • Susan Stramer, Ph.D · American National Red Cross

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2012-01-31
Completion
2012-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01467024 on ClinicalTrials.gov